Stride (NYSE:LRN – Get Free Report) had its price target increased by investment analysts at Canaccord Genuity Group from $100.00 to $130.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 7.88% from the company’s current price.
Several other research analysts have also commented on the company. Morgan Stanley raised their price target on Stride from $94.00 to $109.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 12th. Citigroup lifted their target price on Stride from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, October 29th. StockNews.com lowered shares of Stride from a “buy” rating to a “hold” rating in a research note on Wednesday, October 23rd. BMO Capital Markets upped their target price on shares of Stride from $84.00 to $88.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Finally, Barrington Research raised their price target on shares of Stride from $100.00 to $130.00 and gave the company an “outperform” rating in a research report on Friday, January 17th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Stride has an average rating of “Moderate Buy” and an average target price of $107.50.
Get Our Latest Stock Report on Stride
Stride Stock Performance
Stride (NYSE:LRN – Get Free Report) last posted its earnings results on Tuesday, January 28th. The company reported $2.03 EPS for the quarter, beating analysts’ consensus estimates of $1.92 by $0.11. Stride had a net margin of 11.38% and a return on equity of 21.23%. On average, analysts expect that Stride will post 6.64 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. R Squared Ltd purchased a new stake in shares of Stride during the 4th quarter worth $37,000. Mendota Financial Group LLC acquired a new stake in Stride in the third quarter valued at $86,000. TD Private Client Wealth LLC raised its stake in Stride by 27.7% in the third quarter. TD Private Client Wealth LLC now owns 1,962 shares of the company’s stock valued at $167,000 after buying an additional 426 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Stride by 45.3% during the 3rd quarter. GAMMA Investing LLC now owns 2,061 shares of the company’s stock worth $176,000 after buying an additional 643 shares during the last quarter. Finally, Central Pacific Bank Trust Division boosted its position in shares of Stride by 24.2% during the 3rd quarter. Central Pacific Bank Trust Division now owns 2,153 shares of the company’s stock worth $184,000 after acquiring an additional 420 shares in the last quarter. Institutional investors and hedge funds own 98.24% of the company’s stock.
About Stride
Stride, Inc, a technology-based education service company, engages in the provision of proprietary and third-party online curriculum, software systems, and educational services in the United States and internationally. Its technology-based products and services enable clients to attract, enroll, educate, track progress, support, and facilitate individualized learning for students.
Further Reading
- Five stocks we like better than Stride
- How to Invest in Insurance Companies: A Guide
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is the Dogs of the Dow Strategy? Overview and Examples
- What Does the Future Hold for Eli Lilly?
- CD Calculator: Certificate of Deposit Calculator
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Stride Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stride and related companies with MarketBeat.com's FREE daily email newsletter.